SEC Form D · filed December 7, 2021
Scopus BioPharma Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Raphael A. Hofstein · New York, NYDirectorAshish P. Sanghrajka · New York, NYDirectorDavid S. Battleman · New York, NYDirectorJoshua Lamstein · Stamford, CTExec · DirectorRobert J. Gibson · New York, NYExec · DirectorDavid P. Weild · New York, NYDirectorPaul E. Hopper · New York, NYDirectorIra S. Greenspan · New York, NYExec · DirectorDavid A. Buckel · Gainesville, FLDirectorPaul E. Hopper · New York, NYDirectorRaphael A. Hofstein · New York, NYDirectorAshish P. Sanghrajka · New York, NYDirectorDavid S. Battleman · New York, NYDirectorIra S. Greenspan · New York, NYExec · DirectorDavid A. Buckel · Gainesville, FLDirectorJoshua Lamstein · New York, NYExec · DirectorRobert J. Gibson · New York, NYExec · DirectorDavid P. Weild · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗